Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2013; 110(04): 626-627
DOI: 10.1160/TH13-05-0407
DOI: 10.1160/TH13-05-0407
T&H Images
Successful treatment of acute portal vein thrombosis with rivaroxaban
Further Information
Publication History
Received:
21 May 2013
Accepted after minor revision:
10 June 2013
Publication Date:
01 December 2017 (online)
-
References
- 1 Thatipelli MR, McBane RD, Hodge DO. et al. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol 2010; 8: 200-205.
- 2 Kearon C, Akl EA, Comerota AJ. et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (Suppl. 02) e419S-e94S.
- 3 Riva N, Donadini MP, Dentali F. et al. Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res 2012; 130 (Suppl. 01) S1-S3.
- 4 Turpie AG, Kreutz R, Llau J. et al. Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor. Thromb Haemost 2012; 108: 876-886.
- 5 Hammerstingl C, Potzsch B, Nickenig G. Resolution of giant left atrial appendage thrombus with rivaroxaban. Thromb Haemost 2013; 109: 583-584.